Efforts Continue to Optimize Immunotherapy in Gastric Cancer
David H. Ilson, MD, PhD, discusses practice-changing trials, the optimal available therapies, and how immunotherapy fits into the future treatment paradigm for gastric cancer.
Source: OncLive